Phosphoric Acid

Phosphoric Acid

SCHEMBL4017633

O=P([O-])([O-])[O-].O=P([O-])([O-])[O-].O=P([O-])([O-])[O-].O=P([O-])([O-])[O-].[Ca+2].[Ca+2].[Ca+2].[K+].[K+].[K+].[Na+].[Na+].[Na+]

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC34A1 Q06495 1/20 0.50
LMNA P02545 4/20 0.40
KDM4E B2RXH2 1/20 0.33
CYP2C19 P33261 1/20 0.33
KMT2A Q03164 1/20 0.33
CA4 P22748 3/20 0.32
CA1 P00915 2/20 0.32
CA5A P35218 2/20 0.32
CA5B Q9Y2D0 2/20 0.32
FDPS P14324 1/20 0.31
FAHD1 Q6P587 1/20 0.31
MAPT P10636 1/20 0.30
BLM P54132 1/20 0.30
PMP22 Q01453 1/20 0.30
CYP2C9 P11712 1/20 0.30
TSHR P16473 1/20 0.30
ALOX12 P18054 1/20 0.30
NFKB1 P19838 1/20 0.30
MAPK1 P28482 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphoric Acid SCHEMBL29146073 0.95 SLC34A1 (0.46) SLC34A1LMNAKDM4ECYP2C19KMT2A
Phosphoric Acid SCHEMBL29208986 0.94 SLC34A1 (0.55) SLC34A1LMNAKDM4ECYP2C19KMT2A
Phosphoric Acid SCHEMBL1164274 0.94
Phosphoric Acid SCHEMBL335987 0.94 SLC34A1 (0.55) SLC34A1LMNAKDM4ECYP2C19KMT2A
Phosphoric Acid SCHEMBL2039374 0.94
Phosphoric Acid SCHEMBL1164853 0.94
Phosphoric Acid SCHEMBL5970842 0.94 SLC34A1 (0.55) SLC34A1LMNAKDM4ECYP2C19KMT2A
Phosphoric Acid SCHEMBL1681241 0.94 LMNA (0.43) SLC34A1LMNAKDM4ECYP2C19KMT2A
Phosphoric Acid SCHEMBL468673 0.94
Phosphoric Acid SCHEMBL1138667 0.94

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120150275-A1 STENTS AND METHODS OF MAKING STENTS MICROPEN TECHNOLOGIES CORPORATION (US) 2012-06-14 US claimed
WO-2012078955-A1 STENTS AND METHODS OF MAKING STENTS MICROPEN TECHNOLOGIES CORPORATION (US) 2012-06-14 WO claimed
EP-1449815-B1 Bioactive rhenanite glass-ceramics IVOCLAR VIVADENT AG (LI) 2009-07-01 EP claimed
US-7074730-B2 Bioactive rhenanite glass ceramic IVOCLAR VIVADENT AG (LI) 2006-07-11 US claimed
US-20040167006-A1 high content of P2O5, CaO and Na2O and particularly suitable as bone replacement material in dentistry. IVOCLAR VIVADENT AG (LI) 2004-08-26 US claimed
US-20250368907-A1 METHOD AND SYSTEM FOR GASIFICATION OF BIOMASS MCGOLDEN LLC (US) 2025-12-04 US disclosed
US-12371621-B2 Method and system for gasification of biomass MCGOLDEN, LLC (US) 2025-07-29 US disclosed
EP-4464307-A1 COSMETIC COMPOSITION AND METHODS OF MAKING THE SAME MPLUS COSMETICS S.R.L. (IT) 2024-11-20 EP disclosed
US-20240374498-A1 COSMETIC COMPOSITION AND METHODS OF MAKING THE SAME MPLUS COSMETICS S.R.L. (IT) 2024-11-14 US disclosed
US-20230348789-A1 Method and System for Gasification of Biomass MCGOLDEN LLC (US) 2023-11-02 US disclosed
US-11613705-B2 Method and system for gasification of biomass MCGOLDEN, LLC (US) 2023-03-28 US disclosed
EP-2812416-B1 METHOD AND SYSTEM FOR GASIFICATION OF BIOMASS MCGOLDEN LLC (US) 2019-04-10 EP disclosed
US-20170156999-A1 PERSONAL CARE COMPOSITION IN A DISSOLVABLE CONTAINER Henkel IP & Holding GmbH (DE) 2017-06-08 US disclosed
EP-2812416-A1 METHOD AND SYSTEM FOR GASIFICATION OF BIOMASS McGolden, Michael (US) 2014-12-17 EP disclosed
US-20140332363-A1 METHOD AND SYSTEM FOR GASIFICATION OF BIOMASS MCGOLDEN, LLC 2014-11-13 US disclosed
WO-2013126211-A1 METHOD AND SYSTEM FOR GASIFICATION OF BIOMASS MCGOLDEN MICHAEL (US) 2013-08-29 WO disclosed
US-20120150275-A1 STENTS AND METHODS OF MAKING STENTS MICROPEN TECHNOLOGIES CORPORATION (US) 2012-06-14 US disclosed
WO-2012078955-A1 STENTS AND METHODS OF MAKING STENTS MICROPEN TECHNOLOGIES CORPORATION (US) 2012-06-14 WO disclosed
US-7074730-B2 Bioactive rhenanite glass ceramic IVOCLAR VIVADENT AG (LI) 2006-07-11 US disclosed
US-20040167006-A1 high content of P2O5, CaO and Na2O and particularly suitable as bone replacement material in dentistry. IVOCLAR VIVADENT AG (LI) 2004-08-26 US disclosed